The Future of Genomics in India: Innovation, Healthcare, and National Growth

Over the past decade, advances in biotechnology, artificial intelligence, and data science have significantly transformed healthcare and life sciences globally. Genomics, the study of an organism’s complete genetic material and its interaction with biological and environmental factors, is emerging as a key driver of innovation across precision medicine, disease prevention, agriculture, and biotechnology. Rapid advancements in technologies such as next-generation sequencing (NGS), gene editing, and AI-enabled genomic analytics are enabling faster diagnostics, personalized treatments, and improved understanding of complex diseases.

As genomics moves beyond research laboratories into mainstream healthcare and industrial applications, countries across the world are investing in national genomics programs, precision medicine initiatives, and genomic data infrastructure. This growing global focus reflects the increasing role of genomics in strengthening healthcare systems, accelerating pharmaceutical innovation, supporting bioeconomies, and improving long-term health resilience.

Globally, the genomics market is projected to exceed USD 133.95 billion by the early 2030s, driven by advancements in precision medicine, AI-driven diagnostics, next-generation sequencing (NGS), and gene-editing technologies such as CRISPR. Countries like the United States, China, and the United Kingdom have already established strong genomics ecosystems supported by clear regulatory frameworks, public investments, and large-scale research initiatives.

India, while still emerging in this space, holds significant strategic advantages. With one of the world’s most genetically diverse populations, a rapidly expanding healthcare market, and growing capabilities in biotechnology and artificial intelligence, the country has the potential to become a major global player in genomics. The India genomics market generated a revenue of USD 468.7 million in 2024 and is expected to reach USD 1,861.6 million by 2033, with AI-led genomics applications witnessing even faster expansion.

Genomics is increasingly becoming important for India across multiple dimensions. In healthcare, it can improve early disease detection, enable personalized treatment, strengthen rare disease diagnosis, and enhance cancer care. In agriculture and food systems, genomics can support climate-resilient crops and precision breeding. At a national level, genomic research can strengthen India’s bioeconomy, innovation ecosystem, and long-term health security.

However, the rapid expansion of genomics also brings increasing attention to areas such as data privacy, ethical usage, informed consent, and cross-border sharing of genomic information. Given the sensitive nature of genomic data and its broader implications for individuals and families, there is a growing need for clear and consistent frameworks that support responsible data governance, quality standards, and secure collaboration while enabling innovation and research.

A balanced and forward-looking approach is therefore essential to ensure that India can fully leverage the benefits of genomics while safeguarding national interests.

The Way Forward for India

Encourage the development of a future-ready genomics ecosystem supported by robust data governance practices, privacy safeguards, informed consent mechanisms, and ethical standards.
Strengthen public-private collaboration to accelerate innovation, research, and indigenous technology development.
Promote integration of genomics into mainstream healthcare through standardization, affordability, and capacity building.
Encourage skill development, academic research, and interdisciplinary training to build a strong genomics workforce ecosystem.

Conclusion

As genomics reshapes the future of healthcare, biotechnology, and precision medicine, India stands at a pivotal moment to build a globally competitive and self-reliant genomics ecosystem. A collaborative and innovation-driven approach involving government, industry, academia, healthcare institutions, and research organizations will be essential in shaping India’s long-term leadership in this sector.

In this direction, the Confederation of Indian Industry (CII) is constituting a National Task Force on Genomics under the leadership of Mr Kris Gopalakrishnan. The Task Force brings together experts from industry, hospitals, laboratories, research institutions, and associations to foster dialogue and strategic collaboration for strengthening India’s genomics ecosystem.

To enable collaborations, CII is also developing a compendium of industry case studies highlighting innovations in genomics, genetics, and allied fields, along with another compendium mapping academic courses and institutional capabilities in genomics and related domains across India.

For further information or to express interest, please contact:

Preet Singh Gusai
preet.gusai@cii.in

References:

Grand View Research. (n.d.). India genomics market size, share & trends analysis report. Grand View Research. Retrieved May 21, 2026, from Click Here
Research Nester. (n.d.). Genomics market size, forecast report 2025–2037. Research Nester. Retrieved May 21, 2026, from Click Here